CN Patent

CN115813930A — 大环化合物与mek抑制剂联用在用于治疗疾病药物中的用途

Assigned to Scinnohub Pharmaceutical Co Ltd · Expires 2023-03-21 · 3y expired

What this patent protects

本发明提供一种所示式(I)化合物或其药学上可接受的盐，立体异构体，联合MEK抑制剂在制备治疗疾病药物中的用途。

USPTO Abstract

本发明提供一种所示式(I)化合物或其药学上可接受的盐，立体异构体，联合MEK抑制剂在制备治疗疾病药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN115813930A
Jurisdiction
CN
Classification
—
Expires
2023-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Scinnohub Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.